Opus genetics phone number
WebOpus Genetics’ mission is to pave a proven, derisked, efficient path to the clinic for these urgently needed new therapies. Our programs address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). We continue to develop novel gene therapies for many of the other ...
Opus genetics phone number
Did you know?
WebSep 22, 2024 · RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditions The Foundation in the News ... Phone: (800) 683-5555 6925 Oakland Mills Road, #701, Columbia, MD 21045. Donations can be mailed directly to: Foundation Fighting Blindness, P.O. Box 45740, Baltimore, MD 21297-5740 ... WebOpus Genetics has 2 board members and advisors, including Rusty Kelley. Contacts Job Department Search Contacts... Joe Schachle Chief Operating Officer Executive Finance , …
WebSep 12, 2024 · Opus Genetics. RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-first gene therapy company developing treatments for inherited retinal diseases, today ... WebAug 20, 2024 · Contact Information Website opusgtx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other …
WebOpus Genetics 1,612 followers on LinkedIn. Patient-first gene therapy company for orphan inherited retinal diseases Opus Genetics is a groundbreaking clinical-stage gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled … WebDec 28, 2024 · Opus Genetics is a clinical-stage gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’ venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases. Its AAV-based …
WebPhone Number 919-525-9820 Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra …
WebOpus Genetics has an estimated revenue of <$1M and an estimate of less <10 employees. Overview Funding News & Insights. Opus Genetics is headquartered in Durham, North Carolina. Ben Yerxa is the CEO of Opus Genetics. Opus Genetics has raised a total of $28.5M in funding. culligan water guamWebDec 28, 2024 · December 28, 2024. Opus Genetics said it has acquired the rights to two preclinical-stage AAV-based gene therapy product candidates for inherited retinal … culligan water hanoverWebOpus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the Retinal Degeneration Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous inherited retinal diseases. Our ... culligan water hanover onWebDec 2, 2024 · Opus Genetics added, Hope in Focus @HopeinFocus1 We have pledged $300,000 by 2025 to support @OpusGeneticswork to … east goshen friends schoolWebSep 23, 2024 · Opus Genetics, a Raleigh startup using gene therapy technology to treat blindness, raises $19 million from investors. The company’s technology was developed at … east goshen fire companyWebSep 22, 2024 · The University of Pennsylvania also holds equity and licensing interests in Opus Genetics. Media contacts: For The Retinal Degeneration Fund: Jason Menzo 317 … culligan water hamilton mtWebSep 22, 2024 · The lead programs for Opus Genetics, which is based in North Carolina, are aimed at developing therapeutics that will address mutations in genes that cause different forms of Leber congenital amaurosis (LCA), a group of rare inherited retinal diseases that typically present in infancy and are characterized by degeneration of photoreceptors, the … culligan water hanover ontario